← Browse by Condition
Medical Condition

moderate to severe ulcerative colitis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06693908 Phase 1, Phase 2
Recruiting

A Study to Evaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative Colitis

Enrollment
24 pts
Location
Germany
Sponsor
Genentech, Inc.
View Trial →